Late Effects of Langerhans Cell Histiocytosis and Its Association with Malignancy
スポンサーリンク
概要
- 論文の詳細を見る
There is considerable variation in the incidence of the late effects after Langerhans cell histiocytosis (LCH), however, about half of the children with LCH (22-64%) have some late sequelae. The most common late effects are endocrinological problems including central diabetes insipidus (15-50%) and growth hormone deficiency (5-20%). Other common effects were skeletal defects in 15% (2.5-42%) of LCH, dental problems in 3-30%, hearing loss in 3-16%, and other central nervous system dysfunction including cognitive dysfunction and cerebellar involvement in 2-14%. Health-related quality of life was adversely affected in > 50% of patients with multi-system LCH. The association of LCH and malignancy has been described in many reports before today. According to the Malignancy Registry of the Histiocytosis Society, 157 LCH-malignancy cases have been registered. Organ damage from LCH causes long term morbidity extending into adolescent and adult life. Carefully planned, multidisciplinary followup is essential to ensure early recognition of problems with appropriate interventions to reduce the impact on patients' quality of life.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma